Evidence map›Paper›PMID 40061943›Full record

ArticleFrontiers in immunology2025

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.

Ivana Kutle, Robert Polten, Jan Lennart Stalp, Jens Hachenberg, Felix Todzey, Ralf Hass, Katharina Zimmermann, Juliane von der Ohe, Constantin von Kaisenberg, Lavinia Neubert and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Ivana Kutle *Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Robert Polten *Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Jan Lennart StalpInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Jens HachenbergInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Felix TodzeyInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Ralf HassDepartment of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.
Katharina ZimmermannInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Juliane von der OheDepartment of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.
Constantin von KaisenbergDepartment of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.
Lavinia NeubertInstitute of Pathology, Hannover Medical School, Hannover, Germany.
Jan C KampBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
Dirk SchaudienFraunhofer Institute for Toxicology and Experimental Medicine, ITEM, Hannover, Germany.
Ann-Kathrin SeydaInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Peter HillemannsDepartment of Gynecology and Obstetrics, Hannover Medical School, Hannover, Germany.
Rüdiger KlapdorInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Michael Alexander MorganInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
Axel SchambachInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2024.1485461.].

Indexed as

CAR-NK cellsCAR-T cellscervical cancerchemotherapychimeric antigen receptor (CAR)immunotherapyMesothelin

Identifiers

PMID40061943
PMCPMC11885913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.